How has the pandemic impacted pediatric endocrinology?
Significantly fewer tests to diagnose growth hormone deficiency (GHD) were conducted during the COVID-19 pandemics while there was a clinically meaningful increase in cases of central precocious puberty (CPP) in girls, according to a study aimed to determine the impact COVID-19 had on pediatric endocrine.
In this retrospective study, researchers analyzed data collected for pediatric endocrine stimulation tests between 2019 and 2020 in a tertiary center.
In 2019, 278 tests were performed on 206 patients compared to in 2019, in which, 251 tests were performed on 190 patients. There was a 35% reduction in tests to diagnose GHD and a 30% reduction in diagnoses. There was a 38% increase in CPP diagnosis in 2020 compared to 2019.
Peinkhofer M, Bossini B, Penco A, et al. Reduction in pediatric growth hormone deficiency and increase in central precocious puberty diagnoses during COVID 19 pandemics. Ital J Pediatr. 2022;48(1):49. doi: 10.1186/s13052-022-01238-1. PMID: 35346309; PMCID: PMC8960104.